Popular anxiety drug clonazepam recalled for labeling error
Additional packages of clonazepam, a prescription medication used to treat seizures and anxiety, mislabeled with the incorrect strength have been added to a voluntary recall, according to the U.S. Food and Drug Administration.
Some Clonazepam Pills Recalled Over Incorrect Doses on Label, F.D.A. Says
The agency warned that adults and children who inadvertently took a higher dose of clonazepam than prescribed could experience side effects, including “significant” sedation, confusion, dizziness, diminished reflexes, the loss of muscle control and muscle weakness.
Clonazepam Recall Grows Over Potentially Life-Threatening Label Error
Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life-threatening consequences.
Anxiety drug clonazepam recalled due to potentially 'life-threatening' labeling error
Clonazepam, an anxiety drug, has been recalled because of a labeling error that could result in harmful consequences.
Clonazepam tablets recalled over ‘life-threatening’ label mistake
The company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.
Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error
The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.
Nationwide Recall of Anxiety Drug Over Life-Threatening Packaging Error
Endo Inc., based in Pennsylvania, has announced a voluntary recall of 16 lots of Clonazepam Orally Disintegrating Tablets after it discovered that a number of cartons may have been printed with the incorrect strength and National Drug Code (NDC) on them.
Recall expended nationwide for clonazepam due to labeling error
Endo, Inc., has expanded its voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to mislabeled carton strength and NDC numbers caused by a packaging error.
Clonazepam recall expanded after misprinting on packaging
The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.
Manufacturer issues recall of popular anxiety drug
Drug manufacturer Endo announced on Friday that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, a popular anxiety drug,
Popular anxiety drug recalled over potentially ‘life-threatening’ issue
The US Food and Drug Administration said taking wrong dose of Clonazepam could result in ‘significant sedation, confusion, dizziness, diminished reflexes, ataxia, and hypotonia’
Monthly Prescribing Reference4d
More Clonazepam ODT Recalled Due to Carton Strength Mislabeling
Endo has expanded the recall of Clonazepam Orally Disintegrating Tablets (ODT) to include additional lots that may ...
Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its ...